Resources from the same session
662MO - Phase I, multi-center, dose-escalation and dose-expansion study of IMP7068, a WEE1 inhibitor, in patients with advanced solid tumors
Presenter: Chia-Chi Lin
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast